AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sunitax 12.5 Capsule

Prescription Icon
Prescription Required

Marketer

Aureate Healthcare Pvt Ltd

Salt Composition

Sunitinib (12.5mg)

Overview Sunitax 12.5 Capsule

Sunitax 12.5mg capsules treat kidney cancer and gastrointestinal stromal tumors by inhibiting enzymes that fuel cancer cell proliferation. This action reduces tumor size and growth rate. Administer this medication with or without food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include fatigue, diarrhea, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring are often recommended. Hypoglycemia, potentially severe enough to cause fainting, is possible; diabetics must monitor blood glucose levels closely and discuss potential anti-diabetic medication adjustments with their doctor. Prior to commencement, inform your doctor of any pre-existing heart, liver, kidney, or bleeding disorders. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.

Primary Ingredients of Sunitax 12.5 Capsule

No text provided. Please provide the text you wish me to rephrase.

Uses of Sunitax 12.5 Capsule

Managing renal cell carcinoma and gastrointestinal stromal tumors

Major Benefits of Sunitax 12.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sunitax 12.5 Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

Common Side effects of Sunitax 12.5 Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Sunitax 12.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sunitax 12.5 Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

How Sunitax 12.5 Capsule works:

Sunitax 12.5mg capsules are an anti-neoplastic agent. Their mechanism of action involves targeted inhibition of tyrosine kinase receptors on cancer cells, thereby disrupting crucial signaling pathways that drive tumor development. Additionally, the drug impedes angiogenesis, the formation of new blood vessels that nourish tumors, thus limiting cancer progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol and Sunitax 12.5 Capsule is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sunitax 12.5 Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sunitax 12.5 Capsule while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Sunitax 12.5 Capsules might lead to adverse reactions that impair driving ability. Dizziness is a possible side effect. Refrain from driving or operating equipment should dizziness occur during treatment.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney impairment can safely take Sunitax 12.5 Capsules without requiring a dosage modification.

LiverLiverSAFE IF PRESCRIBED

Patients with liver impairment can safely take Sunitax 12.5 Capsules without requiring a modified dosage.

What if you forget to take Sunitax 12.5 Capsule :

Omit any missed Sunitax 12.5 Capsule dose and resume your regular dosing regimen. Avoid taking a double dose.

Facts to Know About Sunitax 12.5 Capsule

LabelValue
Type of Compound Indole- and pyrrole-containing compounds
Addictive None.
Type of Medication Cancer therapies

FAQs on Sunitax 12.5 Capsule

Follow your doctor's instructions precisely when using Sunitax 12.5 Capsule. Only oncologists experienced in cancer therapy should initiate treatment. Administer once daily, with or without food. Avoid grapefruit juice and grapefruit while taking Sunitax 12.5 Capsule to minimize the risk of adverse reactions.
Skin lightening and hair loss can occur during Sunitax 12.5 Capsule therapy. Patients may also experience dry, thickened, or cracked skin, blisters, or rashes on their hands and feet. These side effects typically resolve upon discontinuation of the medication. However, Sunitax 12.5 Capsule can cause serious, potentially fatal, skin reactions including severe rashes or rapidly progressing skin sores. Report any signs of infection near a skin wound, such as fever, pain, redness, swelling, or pus or blood discharge, to your physician immediately.
Sunitax 12.5 Capsule carries a risk of severe hepatic complications, potentially fatal. Report immediately to your physician any symptoms including jaundice (yellowing of the eyes or skin), dark urine, or abdominal pain (specifically in the right upper quadrant). Your physician will monitor liver function via blood tests prior to, and throughout, Sunitax 12.5 Capsule treatment. Should liver problems arise, your doctor may suspend or discontinue the medication.
Sunitax 12.5 Capsule currently lacks generic alternatives. Its mechanism of action involves inhibiting a protein kinase enzyme crucial for cancer cell proliferation and metastasis. This enzyme resides on the surface of cancerous cells; its blockage by Sunitax hinders cancer progression. Other medications that similarly target protein kinases include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
No research validates combining Sunitinib 12.5 mg capsules with other chemotherapy agents. Specifically, Sunitinib 12.5 mg capsules treat gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, when imatinib, an alternative anticancer drug, proves ineffective or is unsuitable for the patient.
Sunitax 12.5 Capsules can lower blood glucose. Diabetic patients should monitor their blood sugar closely, as hypoglycemia leading to unconsciousness is possible. Anti-diabetic medication dosage adjustments may be necessary depending on blood glucose readings.
Sunitax 12.5 Capsule commonly elevates blood pressure. Consequently, consistent blood pressure monitoring is crucial. Report severe headache, dizziness, lightheadedness, or visual disturbances to your physician immediately. They may then prescribe antihypertensive medication or temporarily suspend your Sunitax treatment until your blood pressure normalizes.
Sunitax 12.5 Capsule
616
MRP 750
17% off